Stay updated on CTX001 in Severe Sickle Cell: Clinical Trial
Sign up to get notified when there's something new on the CTX001 in Severe Sickle Cell: Clinical Trial page.

Latest updates to the CTX001 in Severe Sickle Cell: Clinical Trial page
- Check5 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1. The 'Back to Top' element was removed as a minor UI change.SummaryDifference0.2%
- Check12 days agoChange DetectedThe web page has been updated to reflect a new version (v3.0.1) and includes a significant addition regarding improvements in health-related quality of life for patients with severe sickle cell disease after a specific treatment.SummaryDifference2%
- Check19 days agoChange DetectedThe webpage has undergone significant updates, including the addition of detailed drug information for Exagamglogene Autotemcel and the inclusion of new research articles related to sickle cell disease. Additionally, the facility name and location have been specified, enhancing the core content of the page.SummaryDifference11%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page has been updated to reflect a new version (v2.16.12) and includes new dates for events in August 2025, while removing outdated dates from October 2024 and July 2025.SummaryDifference1%
- Check40 days agoChange DetectedThe web page has been updated from version v2.16.10 to v2.16.11, indicating a revision in the content.SummaryDifference0.1%
- Check48 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference1%
Stay in the know with updates to CTX001 in Severe Sickle Cell: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTX001 in Severe Sickle Cell: Clinical Trial page.